Are Gifts From Pharmaceutical Companies Ethically Problematic?
A Survey of Physicians
Allan S. Brett, MD;
Wayne Burr, MD;
Jamaluddin Moloo, MD, MPH
Arch Intern Med. 2003;163:2213-2218.
Background Personalized pharmaceutical marketing to physicians, including the provision of gifts and sponsorship of educational and recreational activities, raises ethical issues. We sought to determine the degree to which physicians regarded common pharmaceutical marketing activities as ethically problematic, and to compare the views of experienced physicians and physicians-in-training.
Methods A questionnaire that included 18 scenarios portraying interactions between physicians and the pharmaceutical industry was distributed to residents and faculty members at a US medical school.
Results Most marketing activities were not thought to pose major ethical problems. Respondents tended to make distinctions about the ethical appropriateness of gifts on the basis of the monetary value and type of gift. Some respondents' views would be in violation of recent professional guidelines that address interactions between physicians and pharmaceutical companies. However, some respondents were troubled by activities that are permitted by professional guidelines. The responses of residents and faculty physicians were similar.
Conclusions Despite the recent publicity about ethical problems in relationships between physicians and the pharmaceutical industry, inexperienced and experienced physicians at a single institution continue to have a rather permissive view about a variety of marketing activities.
From the Department of Medicine, University of South Carolina School of Medicine, Columbia. The authors have no relevant financial interest in this article.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
To What Extent Do Educational Interventions Impact Medical Trainees' Attitudes and Behaviors Regarding Industry-Trainee and Industry-Physician Relationships?
Carroll et al.
Pediatrics 2007;120:e1528-e1535.
ABSTRACT
| FULL TEXT
Strategic approach for improving the medication-use process in health systems: The high-performance pharmacy practice framework
Vermeulen et al.
Am J Health Syst Pharm 2007;64:1699-1710.
ABSTRACT
| FULL TEXT
The High Cost of Free Lunch
Wall and Brown
Obstet Gynecol 2007;110:169-173.
ABSTRACT
| FULL TEXT
Effects of Using Free Sample Medications on the Prescribing Practices of Family Physicians
Symm et al.
J Am Board Fam Med 2006;19:443-449.
ABSTRACT
| FULL TEXT
Educational governance for the regulation of industry sponsored continuing medical education in interventional and device based therapies
Morgan et al.
Heart 2005;91:710-712.
ABSTRACT
| FULL TEXT
Doctors and Drug Companies
Blumenthal
NEJM 2004;351:1885-1890.
FULL TEXT
Factors that Influence Prescribing Decisions
Schumock et al.
The Annals of Pharmacotherapy 2004;38:557-562.
ABSTRACT
| FULL TEXT
Minerva
BMJ 2003;327:1058-1058.
FULL TEXT
|
